Pharmaceutical glycerin based products market to witness significant growth due to expanding usage of glycerin to treat illnesses like glaucoma that elevate eye pressure and replacing alcohol in hand sanitizers with more glycerin.

Market Research Future (MRFR) has published a cooked research report on the “Global Pharmaceutical Glycerin Based Products Market” that contains information from 2018 to 2032. The pharmaceutical glycerin based products market is estimated to register a CAGR of 12.10% during the forecast period of 2023 to 2032.

Pharmaceutical Glycerin Based Products Market Highlights

The global pharmaceutical glycerin based products market is accounted to register a CAGR of 12.10% during the forecast period and is estimated to reach USD 0.550 Billion by 2032.

The market for pharmaceutical glycerin-based products grows due to their use in various medications, creams, and ointments. Glycerin's properties as a moisturizer and excipient drive its incorporation into pharmaceutical formulations, contributing to market growth.

MRFR recognizes the following companies as the key players in the global pharmaceutical glycerin based products market— Capsugel, dupoint, AbbVie Inc, Croda International plc, Emery Oleochemicals, Johnson and Johnson, Bausch Health Companies Inc., Abbott Laboratories, Takeda Pharmaceutical Company, The Dow Chemical Company, Takeda Pharmaceutical Company Ltd.

Segment Analysis

The global pharmaceutical glycerin based products market has been segmented drug type.

On the basis of drug type, the market is segmented into dermatological, opthalmic, cough remidies, glycerine rectal and angina. The dermatological segment dominated the market in 2022. Glycerin is a frequent ingredient in dermatological products used to treat and manage a variety of conditions because of its hydrating and moisturizing properties.

Regional Analysis

The global pharmaceutical glycerin based products market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe pharmaceutical glycerin based products market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The pharmaceutical glycerin based products market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World pharmaceutical glycerin based products market comprises of Middle East, Africa, and Latin America.

The North America pharmaceutical glycerin based products market dominated this market in 2022 (45.80%). Glycerin-based topical medicines are made by pharmaceutical companies in North America for conditions like eczema and psoriasis. Different treatments aim to reduce the itching, redness, and inflammation caused by various skin disorders. The demand for effective and safe treatments for chronic skin problems is what is fueling the growth of this market segment.

Moreover, Europe holds the second-largest market share for glycerin-based pharmaceutical products. In Europe, glycerin-based products that offer gentle, all-natural skincare treatments are in high demand. In accordance with the region's concentration on skincare products that are both safe and effective, consumers in Europe favor products with few chemicals and allergens. Due of its moisturizing properties, glycerin is a favored component in these formulations.

Additionally, the Asia-Pacific pharmaceutical glycerin based products market is expected to grow at the fastest CAGR from 2023 to 2032. In many Asian cultures, natural and herbal remedies are valued. Glycerin is suitable for formulations that adhere to customs and preferences because it can be generated from plant sources.

Furthermore, the rest of the world's pharmaceutical glycerin based products market is divided into the Middle East, Africa, and Latin America. The pharmaceutical glycerin-based products market in Latin America is on the rise, driven by its use in medications and skincare items. Glycerin's moisturizing properties and its incorporation into pharmaceutical formulations fuel market demand in the region.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Pharmaceutical Glycerin Based Products Market Research Report

Key Findings of the Study

• The global pharmaceutical glycerin based products market is expected to reach USD 0.550 Billion by 2032, at a CAGR of 12.10% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market Natural and herbal medicines are preferred in many Asian cultures. Since it may be made from plant sources, glycerin is appropriate for formulations that follow customs and preferences.


• Based on drug type, the dermatological segment was attributed to holding the largest market in 2022.


• Capsugel, dupoint, AbbVie Inc, Croda International plc, Emery Oleochemicals, Johnson and Johnson, Bausch Health Companies Inc., Abbott Laboratories, Takeda Pharmaceutical Company, The Dow Chemical Company, Takeda Pharmaceutical Company Ltd. and others